FDA 483 - Galbraith Laboratories Inc - March 02, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Galbraith Laboratories Inc, a control testing laboratory in Knoxville, TN, revealed significant deficiencies in their quality systems. The firm failed to perform routine inspections and audit trail reviews for electronic equipment, and their quality control unit lacked the authority to properly investigate errors and oversee the CAPA system. These issues indicate a need for improved adherence to written procedures and quality assurance practices.
ID · 67d2319b-7e82-4720-b800-0978b4a88632